Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 243Stomach Neoplasms 23Breast Neoplasms, Male 16Neoplasm Metastasis 14Neoplasms 8Inflammatory Breast Neoplasms 8Esophageal Neoplasms 8Brain Neoplasms 8Colorectal Neoplasms 6Adenocarcinoma Of Esophagus 4Urologic Neoplasms 3Triple Negative Breast Neoplasms 3HER2-positive Breast Cancer 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Ductal, Breast 3Gallbladder Neoplasms 2Endometrial Neoplasms 2Cholangiocarcinoma 2Carcinoma, Lobular 2Carcinoma, Intraductal, Noninfiltrating 2Biliary Tract Neoplasms 2Adenocarcinoma 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Solid Cancers 1Rectal Neoplasms 1Prostatic Neoplasms 1Patient Preference 1Patient Compliance 1

Interventions

Gemcitabine 13Cisplatin 8Capecitabine 8Fluorouracil 5pembrolizumab 4Oxaliplatin 4Sorafenib 3Leucovorin 3Erlotinib Hydrochloride 3trametinib 2regorafenib 2durvalumab 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Magnetic Resonance Spectroscopy 2Lapatinib 2trifluridine tipiracil drug combination 1tremelimumab 1spartalizumab 1seribantumab 1olutasidenib 1olaparib 1devimistat 1derazantinib 1dehydroftorafur 1cediranib 1cabozantinib 1Trifluridine 1Trastuzumab 1Therapeutics 1Sutures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bile Duct Neoplasms × Trastuzumab × Clear all
NCT00478140 2019-08-20

Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Terminated
4 enrolled 6 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡